Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Options Exercise | $346K | +8.13K | +37.1% | $42.62 | 30K | Feb 24, 2025 | Direct | |
transaction | MEDP | Common Stock | Sale | -$1.38M | -4K | -13.33% | $345.59 | 26K | Feb 24, 2025 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Stock Option (Right to Buy) | Options Exercise | $0 | -8.13K | -100% | $0.00 | 0 | Feb 24, 2025 | Common Stock | 8.13K | $42.62 | Direct | F2 |
Id | Content |
---|---|
F1 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $344.798 to $346.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F2 | The option vested in full on May 16, 2019. |